Your browser doesn't support javascript.
loading
Development of Immunotherapy Combination Strategies in Cancer.
Yap, Timothy A; Parkes, Eileen E; Peng, Weiyi; Moyers, Justin T; Curran, Michael A; Tawbi, Hussein A.
Afiliação
  • Yap TA; Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, Texas. tyap@mdanderson.org.
  • Parkes EE; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Peng W; Khalifa Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Moyers JT; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Curran MA; Oxford Institute of Radiation Oncology, University of Oxford, Oxford, United Kingdom.
  • Tawbi HA; Department of Biology and Biochemistry, University of Houston, Houston, Texas.
Cancer Discov ; 11(6): 1368-1397, 2021 06.
Article em En | MEDLINE | ID: mdl-33811048
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2021 Tipo de documento: Article